tiprankstipranks
Analyst Profile
Followed by 67 other investors
.
Y Katherine Xu

Y Katherine Xu

William Blair
Wall Street Analyst
Ranked #1,217 out of 8,050 Analysts on TipRanks (#2,178 out of 21,576 overall experts)

Success Rate

46%
38 out of 82 Profitable Transactions

Average Return

15.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Y Katherine Xu's ratings since 2012 and opened each position for the duration of 1 Year:
46.34% of your transactions would have been profitable with an average return of 15.2%

Stock Rating Distribution

109Ratings
80.73% Buy
17.43% Hold
1.83% Sell
Distribution of Y Katherine Xu's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Arrowhead Pharmaceuticals, Inc.
(ARWR)
Rating Type:Buy
Dates:Sep 18, 2017 - Sep 18, 2018
Gain:469.10%
The most profitable rating made by Y Katherine Xu

Y Katherine Xu's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
IDIX
Idenix Pharma
May 16, 2012
Buy
Reiterated
0%
-44.90%
2
DNDNQ
Dendreon Corp
Nov 12, 2013
Sell
Assigned
100%
+93.70%
1
ITMN
InterMune
Aug 25, 2014
Buy
Reiterated
20%
-44.48%
6
PCYC
Pharmacyclics
Sep 15, 2014
Buy
Reiterated
67%
+73.80%
3
~ACHN
Achillion Pharmaceuticals
Aug 10, 2015
Buy
Reiterated
80%
+33.78%
7
Achieve Life Sciences
Sep 23, 2015
Buy
Reiterated
$6.00
(16.73% Upside)
0%
-60.70%
3
Chimerix
Dec 29, 2015
Hold
Downgraded
$12.00
(347.76% Upside)
33%
-54.53%
5
aTyr Pharma
Mar 31, 2016
Hold
Downgraded
$8.00
(92.77% Upside)
0.00%
1
MDVN
Medivation
Apr 26, 2016
Buy
Reiterated
80%
+109.76%
6
Infinity Pharma
Jun 15, 2016
Hold
Downgraded
$2.00
(30.72% Upside)
0%
-45.60%
5
List of latest recommendations made by Y Katherine Xu. Click to expand and see Y Katherine Xu's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More